Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 12c

November 7, 2017 4:36 PM EST

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q3 EPS of ($0.68), $0.12 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $305 thousand versus the consensus estimate of $300 thousand.

Financial Guidance

Today the Company provided operating expense guidance for the fourth quarter and full... More